Folate action in nervous system development and disease

Developmental Neurobiology

Volumn 78, Issue 4, 2018, Pages 391-402

  Balashova, Olga A ^a   Visina, Olesya ^a   Borodinsky, Laura N ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

folate receptor; folic acid; neural tube defects

Indexed keywords

FOLATE TRANSPORTER; FOLIC ACID;

ADHERENS JUNCTION; BRAIN MATURATION; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SURFACE; CELLULAR DISTRIBUTION; CLINICAL OUTCOME; DNA SYNTHESIS; DRUG MECHANISM; ENDOCYTOSIS; FOLATE METABOLISM; FORTIFIED FOOD; HUMAN; NERVOUS SYSTEM DEVELOPMENT; NERVOUS TISSUE; NEURAL TUBE DEFECT; NEUROECTODERM; NEUROLOGIC DISEASE; NEURULATION; NONHUMAN; NUCLEIC ACID SYNTHESIS; PRIORITY JOURNAL; REVIEW; VITAMIN SUPPLEMENTATION; ANIMAL; GROWTH, DEVELOPMENT AND AGING; METABOLISM; NERVOUS SYSTEM;

ANIMALS; FOLIC ACID; HUMANS; NERVOUS SYSTEM; NERVOUS SYSTEM DISEASES;

EID: 85041603138     PISSN: 19328451     EISSN: 1932846X     Source Type: Journal    
DOI: 10.1002/dneu.22579     Document Type: Review

References (125)

1. MRC Vitamin Study Research Group. 1991. Prevention of neural tube defects: Results of the Medical Research Council Vitamin Study. Lancet 338:131–137.
2. Akchiche N, Bossenmeyer-Pourie C, Kerek R, Martin N, Pourie G, Koziel V, Helle D, et al. 2012. Homocysteinylation of neuronal proteins contributes to folate deficiency-associated alterations of differentiation, vesicular transport, and plasticity in hippocampal neuronal cells. Faseb J 26:3980–3992.
3. Amarnath S, Agarwala S. 2017. Cell-cycle-dependent TGFbeta-BMP antagonism regulates neural tube closure by modulating tight junctions. J Cell Sci 130:119–131.
4. Antony AC. 1996. Folate receptors. Annu Rev Nutr 16:501–521.
5. Balashova OA, Visina O, Borodinsky LN. 2017. Folate receptor 1 is necessary for neural plate cell apical constriction during Xenopus neural tube formation. Development 144:1518–1530.
6. Baxter MG, Miller AA, Webster RA. 1973. Some studies on the convulsant action of folic acid. Br J Pharmacol 48:350P–351P.
7. Bazzano LA, Reynolds K, Holder KN, He J. 2006. Effect of folic acid supplementation on risk of cardiovascular diseases: A meta-analysis of randomized controlled trials. JAMA 296:2720–2726.
8. Bhagatji P, Leventis R, Comeau J, Refaei M, Silvius JR. 2009. Steric and not structure-specific factors dictate the endocytic mechanism of glycosylphosphatidylinositol-anchored proteins. J Cell Biol 186:615–628.
9. Bianchi E, Doe B, Goulding D, Wright GJ. 2014. Juno is the egg Izumo receptor and is essential for mammalian fertilization. Nature 508:483–487.
10. Blom HJ, Shaw GM, den Heijer M, Finnell RH. 2006. Neural tube defects and folate: Case far from closed. Nat Rev Neurosci 7:724–731.
11. Chancy CD, Kekuda R, Huang W, Prasad PD, Kuhnel JM, Sirotnak FM, Roon P, et al. 2000. Expression and differential polarization of the reduced-folate transporter-1 and the folate receptor alpha in mammalian retinal pigment epithelium. J Biol Chem 275:20676–20684.
12. Chen H, Yang J, Low PS, Cheng JX. 2008. Cholesterol level regulates endosome motility via Rab proteins. Biophys J 94:1508–1520.
13. Chen Z, Karaplis AC, Ackerman SL, Pogribny IP, Melnyk S, Lussier-Cacan S, Chen MF, et al. 2001. Mice deficient in methylenetetrahydrofolate reductase exhibit hyperhomocysteinemia and decreased methylation capacity, with neuropathology and aortic lipid deposition. Hum Mol Genet 10:433–443.
14. Cole BF, Baron JA, Sandler RS, Haile RW, Ahnen DJ, Bresalier RS, McKeown-Eyssen G, et al. 2007. Folic acid for the prevention of colorectal adenomas: A randomized clinical trial. JAMA 297:2351–2359.
15. Davies J, Watkins JC. 1973. Facilitatory and direct excitatory effects of folate and folinate on single neurones of cat cerebral cortex. Biochem Pharmacol 22:1667–1668.
16. Davy A, Gale NW, Murray EW, Klinghoffer RA, Soriano P, Feuerstein C, Robbins SM. 1999. Compartmentalized signaling by GPI-anchored ephrin-A5 requires the Fyn tyrosine kinase to regulate cellular adhesion. Genes Dev 13:3125–3135.
17. Desai A, Sequeira JM, Quadros EV. 2016. The metabolic basis for developmental disorders due to defective folate transport. Biochimie 126:31–42.
18. Eitenmiller RR, Landen WO. 1999. Vitamin analysis for the health and food sciences. Boca Raton: CRC Press. 518 p.
19. Elnakat H, Gonit M, Salazar MD, Zhang J, Basrur V, Gunning W, Kamen B, et al. 2009. Regulation of folate receptor internalization by protein kinase C alpha. Biochemistry 48:8249–8260.
20. Eom DS, Amarnath S, Fogel JL, Agarwala S. 2011. Bone morphogenetic proteins regulate neural tube closure by interacting with the apicobasal polarity pathway. Development 138:3179–3188.
21. Eom DS, Amarnath S, Fogel JL, Agarwala S. 2012. Bone morphogenetic proteins regulate hinge point formation during neural tube closure by dynamic modulation of apicobasal polarity. Birth Defects Res A Clin Mol Teratol 94:804–816.
22. Europe-Finner GN, Newell PC. 1985. Calcium transport in the cellular slime mould Dictyostelium discoideum. FEBS Lett 186:70–74.
23. Figueiredo JC, Grau MV, Haile RW, Sandler RS, Summers RW, Bresalier RS, Burke CA, et al. 2009. Folic acid and risk of prostate cancer: Results from a randomized clinical trial. J Natl Cancer Inst 101:432–435.
24. Finnell RH, Spiegelstein O, Wlodarczyk B, Triplett A, Pogribny IP, Melnyk S, James JS. 2002. DNA methylation in Folbp1 knockout mice supplemented with folic acid during gestation. J Nutr 132:2457S–2461S.
25. Goldman ID. 1971. The characteristics of the membrane transport of amethopterin and the naturally occurring folates. Ann N Y Acad Sci 186:400–422.
26. Grapp M, Just IA, Linnankivi T, Wolf P, Lucke T, Hausler M, Gartner J, et al. 2012. Molecular characterization of folate receptor 1 mutations delineates cerebral folate transport deficiency. Brain 135:2022–2031.
27. Haigo SL, Hildebrand JD, Harland RM, Wallingford JB. 2003. Shroom induces apical constriction and is required for hingepoint formation during neural tube closure. Curr Biol 13:2125–2137.
28. Harris WA, Hartenstein V. 1991. Neuronal determination without cell division in Xenopus embryos. Neuron 6:499–515.
29. Hill RG, Miller AA. 1974. Antagonism by folic acid of presynaptic inhibition in the rat cuneate nucleus. Br J Pharmacol 50:425–427.
30. Hirono H, Wada Y. 1978. Effects of dietary folate deficiency on developmental increase of myelin lipids in rat brain. J Nutr 108:766–772.
31. Iskandar BJ, Nelson A, Resnick D, Skene JH, Gao P, Johnson C, Cook TD, et al. 2004. Folic acid supplementation enhances repair of the adult central nervous system. Ann Neurol 56:221–227.
32. Iskandar BJ, Rizk E, Meier B, Hariharan N, Bottiglieri T, Finnell RH, Jarrard DF, et al. 2010. Folate regulation of axonal regeneration in the rodent central nervous system through DNA methylation. J Clin Invest 120:1603–1616.
33. Itoh K, Ossipova O, Sokol SY. 2014. GEF-H1 functions in apical constriction and cell intercalations and is essential for vertebrate neural tube closure. J Cell Sci 127:2542–2553.
34. Jacobson AG. 1994. Normal neurulation in amphibians. Ciba Found Symp 181:6–21. discussion 21–24.
35. Jacobson AG, Oster GF, Odell GM, Cheng LY. 1986. Neurulation and the cortical tractor model for epithelial folding. J Embryol Exp Morphol 96:19–49.
36. Johansson M, Appleby PN, Allen NE, Travis RC, Roddam AW, Egevad L, Jenab M, et al. 2008. Circulating concentrations of folate and vitamin B12 in relation to prostate cancer risk: Results from the European Prospective Investigation into Cancer and Nutrition study. Cancer Epidemiol Biomarkers Prev 17:279–285.
37. Kamen BA, Caston JD. 1986. Properties of a folate binding protein (FBP) isolated from porcine kidney. Biochem Pharmacol 35:2323–2329.
38. Kamen BA, Smith AK. 2004. A review of folate receptor alpha cycling and 5-methyltetrahydrofolate accumulation with an emphasis on cell models in vitro. Adv Drug Deliv Rev 56:1085–1097.
39. Kamen BA, Wang MT, Streckfuss AJ, Peryea X, Anderson RG. 1988. Delivery of folates to the cytoplasm of MA104 cells is mediated by a surface membrane receptor that recycles. J Biol Chem 263:13602–13609.
40. Kawasaki Y, Xu ZZ, Wang X, Park JY, Zhuang ZY, Tan PH, Gao YJ, et al. 2008. Distinct roles of matrix metalloproteases in the early- and late-phase development of neuropathic pain. Nat Med 14:331–336.
41. Keller R. 2006. Mechanisms of elongation in embryogenesis. Development 133:2291–2302.
42. Kim YI. 1999. Folate and cancer prevention: A new medical application of folate beyond hyperhomocysteinemia and neural tube defects. Nutr Rev 57:314–321.
43. Koch MC, Stegmann K, Ziegler A, Schroter B, Ermert A. 1998. Evaluation of the MTHFR C677T allele and the MTHFR gene locus in a German spina bifida population. Eur J Pediatr 157:487–492.
44. Kronenberg G, Harms C, Sobol RW, Cardozo-Pelaez F, Linhart H, Winter B, Balkaya M, et al. 2008. Folate deficiency induces neurodegeneration and brain dysfunction in mice lacking uracil DNA glycosylase. J Neurosci 28:7219–7230.
45. Kruman II, Kumaravel TS, Lohani A, Pedersen WA, Cutler RG, Kruman Y, Haughey N, et al. 2002. Folic acid deficiency and homocysteine impair DNA repair in hippocampal neurons and sensitize them to amyloid toxicity in experimental models of Alzheimer's disease. J Neurosci 22:1752–1762.
46. Kruman II, Mouton PR, Emokpae R, Jr., Cutler RG, Mattson MP. 2005. Folate deficiency inhibits proliferation of adult hippocampal progenitors. Neuroreport 16:1055–1059.
47. Kur E, Mecklenburg N, Cabrera RM, Willnow TE, Hammes A. 2014. LRP2 mediates folate uptake in the developing neural tube. J Cell Sci 127:2261–2268.
48. Lakhan SE, Sabharanjak S, De A. 2009. Endocytosis of glycosylphosphatidylinositol-anchored proteins. J Biomed Sci 16:93.
49. Lee JY, Harland RM. 2010. Endocytosis is required for efficient apical constriction during Xenopus gastrulation. Curr Biol 20:253–258.
50. Lewis CJ, Crane NT, Wilson DB, Yetley EA. 1999. Estimated folate intakes: Data updated to reflect food fortification, increased bioavailability, and dietary supplement use. Am J Clin Nutr 70:198–207.
51. Martin AC, Kaschube M, Wieschaus EF. 2009. Pulsed contractions of an actin-myosin network drive apical constriction. Nature 457:495–499.
52. Mateus AM, Gorfinkiel N, Schamberg S, Martinez Arias A. 2011. Endocytic and recycling endosomes modulate cell shape changes and tissue behaviour during morphogenesis in Drosophila. PLoS One 6:e18729.
53. Matherly LH, Goldman DI. 2003. Membrane transport of folates. Vitam Horm 66:403–456.
54. Matsunaga E, Tauszig-Delamasure S, Monnier PP, Mueller BK, Strittmatter SM, Mehlen P, Chedotal A. 2004. RGM and its receptor neogenin regulate neuronal survival. Nat Cell Biol 6:749–755.
55. Mattson MP, Shea TB. 2003. Folate and homocysteine metabolism in neural plasticity and neurodegenerative disorders. Trends Neurosci 26:137–146.
56. Mayor S, Sabharanjak S, Maxfield FR. 1998. Cholesterol-dependent retention of GPI-anchored proteins in endosomes. embo J 17:4626–4638.
57. McRobbie SJ, Newell PC. 1983. Changes in actin associated with the cytoskeleton following chemotactic stimulation of dictyostelium discoideum. Biochem Biophys Res Commun 115:351–359.
58. Mentch SJ, Locasale JW. 2016. One-carbon metabolism and epigenetics: Understanding the specificity. Ann N Y Acad Sci 1363:91–98.
59. Meuli M, Moehrlen U. 2014. Fetal surgery for myelomeningocele is effective: A critical look at the whys. Pediatr Surg Int 30:689–697.
60. Milunsky A, Jick H, Jick SS, Bruell CL, MacLaughlin DS, Rothman KJ, Willett W. 1989. Multivitamin/folic acid supplementation in early pregnancy reduces the prevalence of neural tube defects. JAMA 262:2847–2852.
61. Miranda-Morales E, Meier K, Sandoval-Carrillo A, Salas-Pacheco J, Vazquez CP, Arias CO. 2017. Implications of DNA Methylation in Parkinson's Disease. Front Mol Neurosci 10:225.
62. Miranpuri GS, Meethal SV, Sampene E, Chopra A, Buttar S, Nacht C, Moreno N, et al. 2017. Folic acid modulates matrix metalloproteinase-2 expression, alleviates neuropathic pain, and improves functional recovery in spinal cord-injured rats. Ann Neurosci 24:74–81.
63. Miranpuri GS, Schomberg DT, Alrfaei B, King KC, Rynearson B, Wesley VS, Khan N, et al. 2016. Role of matrix metalloproteinases 2 in spinal cord injury-induced neuropathic pain. Ann Neurosci 23:25–32.
64. Mitchell ES, Conus N, Kaput J. 2014. B vitamin polymorphisms and behavior: Evidence of associations with neurodevelopment, depression, schizophrenia, bipolar disorder and cognitive decline. Neurosci Biobehav Rev 47C:307–320.
65. Momb J, Lewandowski JP, Bryant JD, Fitch R, Surman DR, Vokes SA, Appling DR. 2013. Deletion of Mthfd1l causes embryonic lethality and neural tube and craniofacial defects in mice. Proc Natl Acad Sci U S A 110:549–554.
66. Monnier PP, Sierra A, Macchi P, Deitinghoff L, Andersen JS, Mann M, Flad M, et al. 2002. RGM is a repulsive guidance molecule for retinal axons. Nature 419:392–395.
67. Mornet E, Muller F, Lenvoise-Furet A, Delezoide AL, Col JY, Simon-Bouy B, Serre JL. 1997. Screening of the C677T mutation on the methylenetetrahydrofolate reductase gene in French patients with neural tube defects. Hum Genet 100:512–514.
68. Nandadasa S, Tao Q, Menon NR, Heasman J, Wylie C. 2009. N- and E-cadherins in Xenopus are specifically required in the neural and non-neural ectoderm, respectively, for F-actin assembly and morphogenetic movements. Development 136:1327–1338.
69. Nebl T, Fisher PR. 1997. Intracellular Ca2+ signals in Dictyostelium chemotaxis are mediated exclusively by Ca2+ influx. J Cell Sci 110:2845–2853.
70. Nishimura T, Takeichi M. 2008. Shroom3-mediated recruitment of Rho kinases to the apical cell junctions regulates epithelial and neuroepithelial planar remodeling. Development 135:1493–1502.
71. O'Broin JD, Temperley IJ, Brown JP, Scott JM. 1975. Nutritional stability of various naturally occurring monoglutamate derivatives of folic acid. Am J Clin Nutr 28:438–444.
72. O'Byrne MR, Au KS, Morrison AC, Lin JI, Fletcher JM, Ostermaier KK, Tyerman GH, et al. 2010. Association of folate receptor (FOLR1, FOLR2, FOLR3) and reduced folate carrier (SLC19A1) genes with meningomyelocele. Birth Defects Res A Clin Mol Teratol 88:689–694.
73. Ossipova O, Kim K, Lake BB, Itoh K, Ioannou A, Sokol SY. 2014. Role of Rab11 in planar cell polarity and apical constriction during vertebrate neural tube closure. Nat Commun 5:3734.
74. Ossipova O, Kim K, Sokol SY. 2015. Planar polarization of Vangl2 in the vertebrate neural plate is controlled by Wnt and Myosin II signaling. Biol Open 4:722–730.
75. Otis LC, Madison DV, Nicoll RA. 1985. Folic acid has a disinhibitory action in the rat hippocampal slice preparation. Brain Res 346:281–286.
76. Paladino S, Pocard T, Catino MA, Zurzolo C. 2006. GPI-anchored proteins are directly targeted to the apical surface in fully polarized MDCK cells. J Cell Biol 172:1023–1034.
77. Pan M, Xu X, Chen Y, Jin T. 2016. Identification of a chemoattractant g-protein-coupled receptor for folic acid that controls both chemotaxis and phagocytosis. Dev Cell 36:428–439.
78. Papapetrou C, Lynch SA, Burn J, Edwards YH. 1996. Methylenetetrahydrofolate reductase and neural tube defects. Lancet 348:58.
79. Paratcha G, Ledda F, Ibanez CF. 2003. The neural cell adhesion molecule NCAM is an alternative signaling receptor for GDNF family ligands. Cell 113:867–879.
80. Parker N, Turk MJ, Westrick E, Lewis JD, Low PS, Leamon CP. 2005. Folate receptor expression in carcinomas and normal tissues determined by a quantitative radioligand binding assay. Anal Biochem 338:284–293.
81. Peglion F, Llense F, Etienne-Manneville S. 2014. Adherens junction treadmilling during collective migration. Nat Cell Biol 16:639–651.
82. Perez-Duenas B, Ormazabal A, Toma C, Torrico B, Cormand B, Serrano M, Sierra C, et al. 2011. Cerebral folate deficiency syndromes in childhood: Clinical, analytical, and etiologic aspects. Arch Neurol 68:615–621.
83. Perez-Duenas B, Toma C, Ormazabal A, Muchart J, Sanmarti F, Bombau G, Serrano M, et al. 2010. Progressive ataxia and myoclonic epilepsy in a patient with a homozygous mutation in the FOLR1 gene. J Inherit Metab Dis 33:795–802.
84. Piedrahita JA, Oetama B, Bennett GD, van Waes J, Kamen BA, Richardson J, Lacey SW, et al. 1999. Mice lacking the folic acid-binding protein Folbp1 are defective in early embryonic development. Nat Genet 23:228–232.
85. Ratnam M, Marquardt H, Duhring JL, Freisheim JH. 1989. Homologous membrane folate binding proteins in human placenta: Cloning and sequence of a cDNA. Biochemistry 28:8249–8254.
86. Reddy JA, Haneline LS, Srour EF, Antony AC, Clapp DW, Low PS. 1999. Expression and functional characterization of the beta-isoform of the folate receptor on CD34(+) cells. Blood 93:3940–3948.
87. Rijnboutt S, Jansen G, Posthuma G, Hynes JB, Schornagel JH, Strous GJ. 1996. Endocytosis of GPI-linked membrane folate receptor-alpha. J Cell Biol 132:35–47.
88. Rothberg KG, Ying YS, Kolhouse JF, Kamen BA, Anderson RG. 1990. The glycophospholipid-linked folate receptor internalizes folate without entering the clathrin-coated pit endocytic pathway. J Cell Biol 110:637–649.
89. Sabharanjak S, Sharma P, Parton RG, Mayor S. 2002. GPI-anchored proteins are delivered to recycling endosomes via a distinct cdc42-regulated, clathrin-independent pinocytic pathway. Dev Cell 2:411–423.
90. Sanjoaquin MA, Allen N, Couto E, Roddam AW, Key TJ. 2005. Folate intake and colorectal cancer risk: A meta-analytical approach. Int J Cancer 113:825–828.
91. Sausedo RA, Smith JL, Schoenwolf GC. 1997. Role of nonrandomly oriented cell division in shaping and bending of the neural plate. J Comp Neurol 381:473–488.
92. Schoenwolf GC, Alvarez IS. 1989. Roles of neuroepithelial cell rearrangement and division in shaping of the avian neural plate. Development 106:427–439.
93. Schoenwolf GC, Yuan S. 1995. Experimental analyses of the rearrangement of ectodermal cells during gastrulation and neurulation in avian embryos. Cell Tissue Res 280:243–251.
94. Shen F, Ross JF, Wang X, Ratnam M. 1994. Identification of a novel folate receptor, a truncated receptor, and receptor type beta in hematopoietic cells: cDNA cloning, expression, immunoreactivity, and tissue specificity. Biochemistry 33:1209–1215.
95. Shen F, Wu M, Ross JF, Miller D, Ratnam M. 1995. Folate receptor type gamma is primarily a secretory protein due to lack of an efficient signal for glycosylphosphatidylinositol modification: Protein characterization and cell type specificity. Biochemistry 34:5660–5665.
96. Sierra EE, Brigle KE, Spinella MJ, Goldman ID. 1995. Comparison of transport properties of the reduced folate carrier and folate receptor in murine L1210 leukemia cells. Biochem Pharmacol 50:1287–1294.
97. Simpson JL, Mills JL, Rhoads GG, Cunningham GC, Hoffman HJ, Conley MR. 1991. Vitamins, folic acid and neural tube defects: Comments on investigations in the United States. Prenat Diagn 11:641–648.
98. Sirotnak FM, Tolner B. 1999. Carrier-mediated membrane transport of folates in mammalian cells. Annu Rev Nutr 19:91–122.
99. Smith SB, Kekuda R, Gu X, Chancy C, Conway SJ, Ganapathy V. 1999. Expression of folate receptor alpha in the mammalian retinol pigmented epithelium and retina. Invest Ophthalmol Vis Sci 40:840–848.
100. Spector RG. 1972. Influence of folic acid on excitable tissues. Nat New Biol 240:247–249.
101. Speer MC, Worley G, Mackey JF, Melvin E, Oakes WJ, George TM. 1997. The thermolabile variant of methylenetetrahydrofolate reductase (MTHFR) is not a major risk factor for neural tube defect in American Caucasians. The NTD Collaborative Group. Neurogenetics 1:149–150.
102. Spiegelstein O, Mitchell LE, Merriweather MY, Wicker NJ, Zhang Q, Lammer EJ, Finnell RH. 2004. Embryonic development of folate binding protein-1 (Folbp1) knockout mice: Effects of the chemical form, dose, and timing of maternal folate supplementation. Dev Dyn 231:221–231.
103. Spinella MJ, Brigle KE, Sierra EE, Goldman ID. 1995. Distinguishing between folate receptor-alpha-mediated transport and reduced folate carrier-mediated transport in L1210 leukemia cells. J Biol Chem 270:7842–7849.
104. Steinfeld R, Grapp M, Kraetzner R, Dreha-Kulaczewski S, Helms G, Dechent P, Wevers R, et al. 2009. Folate receptor alpha defect causes cerebral folate transport deficiency: A treatable neurodegenerative disorder associated with disturbed myelin metabolism. Am J Hum Genet 85:354–363.
105. Stover PJ. 2009. One-carbon metabolism-genome interactions in folate-associated pathologies. J Nutr 139:2402–2405.
106. Swanson DA, Liu ML, Baker PJ, Garrett L, Stitzel M, Wu J, Harris M, et al. 2001. Targeted disruption of the methionine synthase gene in mice. Mol Cell Biol 21:1058–1065.
107. Tang LS, Santillano DR, Wlodarczyk BJ, Miranda RC, Finnell RH. 2005. Role of Folbp1 in the regional regulation of apoptosis and cell proliferation in the developing neural tube and craniofacies. Am J Med Genet C Semin Med Genet 135C:48–58.
108. Tassew NG, Charish J, Seidah NG, Monnier PP. 2012. SKI-1 and Furin generate multiple RGMa fragments that regulate axonal growth. Dev Cell 22:391–402.
109. van der Put NM, Steegers-Theunissen RP, Frosst P, Trijbels FJ, Eskes TK, van den Heuvel LP, Mariman EC, et al. 1995. Mutated methylenetetrahydrofolate reductase as a risk factor for spina bifida. Lancet 346:1070–1071.
110. van der Put NM, van den Heuvel LP, Steegers-Theunissen RP, Trijbels FJ, Eskes TK, Mariman EC, den Heyer M, et al. 1996. Decreased methylene tetrahydrofolate reductase activity due to the 677C–>T mutation in families with spina bifida offspring. J Mol Med (Berl) 74:691–694.
111. Wallingford JB, Niswander LA, Shaw GM, Finnell RH. 2013. The continuing challenge of understanding, preventing, and treating neural tube defects. Science 339:1222002.
112. Wang M, Van Haastert PJ, Devreotes PN, Schaap P. 1988. Localization of chemoattractant receptors on Dictyostelium discoideum cells during aggregation and down-regulation. Dev Biol 128:72–77.
113. Wang X, Demirtas H, Xu X. 2006. Homocysteine, B vitamins, and cardiovascular disease. N Engl J Med 355:207–209. author reply 209–211.
114. Wang X, Qin X, Demirtas H, Li J, Mao G, Huo Y, Sun N, et al. 2007. Efficacy of folic acid supplementation in stroke prevention: A meta-analysis. Lancet 369:1876–1882.
115. Wang X, Shen F, Freisheim JH, Gentry LE, Ratnam M. 1992. Differential stereospecificities and affinities of folate receptor isoforms for folate compounds and antifolates. Biochem Pharmacol 44:1898–1901.
116. Watanabe K, Bianco C, Strizzi L, Hamada S, Mancino M, Bailly V, Mo W, et al. 2007. Growth factor induction of Cripto-1 shedding by glycosylphosphatidylinositol-phospholipase D and enhancement of endothelial cell migration. J Biol Chem 282:31643–31655.
117. Watanabe K, Nagaoka T, Lee JM, Bianco C, Gonzales M, Castro NP, Rangel MC, et al. 2009. Enhancement of Notch receptor maturation and signaling sensitivity by Cripto-1. J Cell Biol 187:343–353.
118. Watanabe M, Osada J, Aratani Y, Kluckman K, Reddick R, Malinow MR, Maeda N. 1995. Mice deficient in cystathionine beta-synthase: Animal models for mild and severe homocyst(e)inemia. Proc Natl Acad Sci USA 92:1585–1589.
119. Weitman SD, Lark RH, Coney LR, Fort DW, Frasca V, Zurawski VR, Jr, Kamen BA. 1992. Distribution of the folate receptor GP38 in normal and malignant cell lines and tissues. Cancer Res 52:3396–3401.
120. Wilcken DE, Wang XL. 1996. Relevance to spina bifida of mutated methylenetetrahydrofolate reductase. Lancet 347:340.
121. Yang J, Chen H, Vlahov IR, Cheng JX, Low PS. 2007. Characterization of the pH of folate receptor-containing endosomes and the rate of hydrolysis of internalized acid-labile folate-drug conjugates. J Pharmacol Exp Ther 321:462–468.
122. Yumura S. 1994. Rapid translocation of myosin II in vegetative Dictyostelium amoebae during chemotactic stimulation by folic acid. Cell Struct Funct 19:143–151.
123. Zhao R, Goldman ID. 2007. The molecular identity and characterization of a Proton-coupled Folate Transporter–PCFT; biological ramifications and impact on the activity of pemetrexed. Cancer Metastasis Rev 26:129–139.
124. Zhao R, Matherly LH, Goldman ID. 2009a. Membrane transporters and folate homeostasis: Intestinal absorption and transport into systemic compartments and tissues. Expert Rev Mol Med 11:e4.
125. Zhao R, Min SH, Wang Y, Campanella E, Low PS, Goldman ID. 2009b. A role for the proton-coupled folate transporter (PCFT-SLC46A1) in folate receptor-mediated endocytosis. J Biol Chem 284:4267–4274.